BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18706512)

  • 1. Three-dimensional domain architecture of the ADAM family proteinases.
    Takeda S
    Semin Cell Dev Biol; 2009 Apr; 20(2):146-52. PubMed ID: 18706512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview.
    Takeda S
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins.
    Takeda S; Takeya H; Iwanaga S
    Biochim Biophys Acta; 2012 Jan; 1824(1):164-76. PubMed ID: 21530690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.
    Gerhardt S; Hassall G; Hawtin P; McCall E; Flavell L; Minshull C; Hargreaves D; Ting A; Pauptit RA; Parker AE; Abbott WM
    J Mol Biol; 2007 Nov; 373(4):891-902. PubMed ID: 17897672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold.
    Takeda S; Igarashi T; Mori H; Araki S
    EMBO J; 2006 Jun; 25(11):2388-96. PubMed ID: 16688218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ADAM metalloproteinases.
    Edwards DR; Handsley MM; Pennington CJ
    Mol Aspects Med; 2008 Oct; 29(5):258-89. PubMed ID: 18762209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the autolysis of AaHIV suggests a novel target recognizing model for ADAM/reprolysin family proteins.
    Zhu Z; Gao Y; Zhu Z; Yu Y; Zhang X; Zang J; Teng M; Niu L
    Biochem Biophys Res Commun; 2009 Aug; 386(1):159-64. PubMed ID: 19505434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions.
    Reiss K; Saftig P
    Semin Cell Dev Biol; 2009 Apr; 20(2):126-37. PubMed ID: 19049889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM-15 disintegrin-like domain structure and function.
    Lu D; Scully M; Kakkar V; Lu X
    Toxins (Basel); 2010 Oct; 2(10):2411-27. PubMed ID: 22069559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagin VaH4, a covalent heterodimeric P-III metalloproteinase from Vipera ammodytes ammodytes with a potential antitumour activity.
    Leonardi A; Sajevic T; Kovačič L; Pungerčar J; Lang Balija M; Halassy B; Trampuš Bakija A; Križaj I
    Toxicon; 2014 Jan; 77():141-55. PubMed ID: 24269369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins.
    Igarashi T; Araki S; Mori H; Takeda S
    FEBS Lett; 2007 May; 581(13):2416-22. PubMed ID: 17485084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
    Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
    Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of RVV-X: an example of evolutionary gain of specificity by ADAM proteinases.
    Takeda S; Igarashi T; Mori H
    FEBS Lett; 2007 Dec; 581(30):5859-64. PubMed ID: 18060879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
    Sharma D; Singh NK
    Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectodomain shedding and ADAMs in development.
    Weber S; Saftig P
    Development; 2012 Oct; 139(20):3693-709. PubMed ID: 22991436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.
    Yang H; Khalil RA
    Adv Pharmacol; 2022; 94():255-363. PubMed ID: 35659374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis.
    Jones GC; Riley GP
    Arthritis Res Ther; 2005; 7(4):160-9. PubMed ID: 15987500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ADAM and ADAMTS metalloproteinases in airway diseases.
    Paulissen G; Rocks N; Gueders MM; Crahay C; Quesada-Calvo F; Bekaert S; Hacha J; El Hour M; Foidart JM; Noel A; Cataldo DD
    Respir Res; 2009 Dec; 10(1):127. PubMed ID: 20034386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM Metalloproteinases as Potential Drug Targets.
    Camodeca C; Cuffaro D; Nuti E; Rossello A
    Curr Med Chem; 2019; 26(15):2661-2689. PubMed ID: 29589526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.